The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Haldol Decanoate 50mg/ml Solution for Injection

50 milligram(s)/millilitre Solution for injection

Janssen Sciences Ireland UCPA22612/007/001

Main Information

Trade NameHaldol Decanoate 50mg/ml Solution for Injection
Active SubstancesHaloperidol
Strength50 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderJanssen Sciences Ireland UC
Licence NumberPA22612/007/001

Group Information

ATC CodeN05AD Butyrophenone derivatives
N05AD01 haloperidol


Licence Issued10/10/1993
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back